USA - New York Stock Exchange - NYSE:XOM - US30231G1022 - Common Stock
ChartMill assigns a Buy % Consensus number of 75% to XOM. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-06 | Freedom Capital Markets | Downgrade | Hold -> Sell |
| 2026-01-05 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-12-12 | TD Cowen | Maintains | Buy -> Buy |
| 2025-12-12 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-12-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-11 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-12-10 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-12-10 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-12-10 | Jefferies | Maintains | Buy -> Buy |
| 2025-11-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-03 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-10-17 | Wells Fargo | Initiate | Overweight |
| 2025-10-13 | UBS | Maintains | Buy -> Buy |
| 2025-10-09 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-10-07 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-15 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-09-10 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-08-20 | Melius Research | Initiate | Hold |
| 2025-08-20 | UBS | Maintains | Buy -> Buy |
| 2025-08-18 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-04 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-07-11 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-07-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-06-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-05-13 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-05-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-05 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-05 | Barclays | Maintains | Overweight -> Overweight |
33 analysts have analysed XOM and the average price target is 134.86 USD. This implies a price increase of 9.72% is expected in the next year compared to the current price of 122.91.
The consensus rating for EXXON MOBIL CORP (XOM) is 75.1515 / 100 . This indicates that analysts generally have a positive outlook on the stock.